Periodic Reporting for period 4 - DrugComb (Informatics approaches for the rational selection of personalized cancer drug combinations)

Each year we spend more than 100 billion euros on cancer medicine, however, the efficacy is far from optimal, as many cancer drugs benefit at most 25% of the patients who take them. Likewise, pharmaceutical companies have tested hundreds of cancer drugs in clinical trials, but...